U.S. Markets closed
  • S&P Futures

    3,948.50
    +3.50 (+0.09%)
     
  • Dow Futures

    33,670.00
    +37.00 (+0.11%)
     
  • Nasdaq Futures

    11,579.75
    +13.75 (+0.12%)
     
  • Russell 2000 Futures

    1,815.80
    +1.70 (+0.09%)
     
  • Crude Oil

    74.14
    -0.11 (-0.15%)
     
  • Gold

    1,781.80
    -0.60 (-0.03%)
     
  • Silver

    22.26
    -0.07 (-0.34%)
     
  • EUR/USD

    1.0467
    -0.0002 (-0.0209%)
     
  • 10-Yr Bond

    3.5130
    -0.0860 (-2.39%)
     
  • Vix

    22.17
    +1.42 (+6.84%)
     
  • GBP/USD

    1.2132
    -0.0001 (-0.0121%)
     
  • USD/JPY

    137.1280
    +0.1680 (+0.1227%)
     
  • BTC-USD

    17,058.77
    -2.35 (-0.01%)
     
  • CMC Crypto 200

    402.69
    +0.88 (+0.22%)
     
  • FTSE 100

    7,521.39
    -46.15 (-0.61%)
     
  • Nikkei 225

    27,731.38
    -154.49 (-0.55%)
     

This Controversial Growth Stock Could Be a Brilliant Contrarian Pick

Contrarian investing is fun because when you nail a contrarian pick correctly, you get the joy of saying "I told you so!" Seeing the value in opportunities that other investors discard means capturing outsized profits when things go right. Nano-X's product in development is the Nanox.ARC, an X-ray imaging device that's significantly less expensive to operate than traditional X-ray machines used in hospitals worldwide thanks to its innovative low-cost X-ray tubes. The idea is that when paired with the company's artificial intelligence (AI) software package, remote clinics in economically disadvantaged areas that might not have enough money for an X-ray machine or a radiologist can use the Nanox.ARC and pay Nano-X for each scan they perform.